Home  >  Companies  >  SuperDial
SuperDial
Voice AI platform automating outbound healthcare phone calls for tasks like insurance verification, prior authorization, and claims follow-up

Funding

$20.00M

2026

View PDF
Details
Headquarters
San Francisco, CA
CEO
Sam Schwager
Website
Milestones
FOUNDING YEAR
2021

Valuation & Funding

SuperDial raised a $15M Series A in June 2025 led by SignalFire, with participation from Slow Ventures, BoxGroup, and Scrub Capital. The round included $3M in venture debt alongside the equity component.

SuperDial has raised over $20M in total funding to date.

Product

SuperDial is an AI-powered call center built for healthcare revenue cycle management. Healthcare staff create calling scripts by pasting questions they normally ask insurance representatives or selecting from pre-built templates in the web portal.

The platform accepts call requests via REST API, CSV uploads, or direct data entry, and can execute thousands of calls in parallel. Behind the scenes, SuperDial's AI agents use speech-to-text processing and large language models to navigate phone trees, detect hold music, and conduct live conversations with insurance representatives.

When an AI agent encounters unexpected situations such as unclear audio or unfamiliar questions, trained human operators take over the call to complete it. The system captures all conversations as structured data, parsing responses into discrete fields such as deductible amounts, denial reasons, and authorization numbers.

Results return to customers via webhooks or downloadable CSV files for integration with existing billing systems. The platform handles core healthcare workflows, including insurance eligibility verification, prior authorization status checks, claim status inquiries, and provider credentialing processes.

Business Model

SuperDial operates a B2B usage-based SaaS model targeting healthcare revenue cycle teams. Customers pay per completed call rather than through traditional seat-based subscriptions, aligning costs directly with value delivered.

The platform integrates with existing healthcare workflows through APIs and standard data formats, requiring minimal implementation overhead. SuperDial maintains HIPAA and SOC 2 compliance to meet healthcare regulatory requirements, completing its SOC 2 audit in November 2025.

The company's cost structure includes cloud infrastructure, telephony services, and human oversight operations. SuperDial employs trained analysts who monitor AI performance and intervene when calls require human judgment, ensuring consistent success rates while building training data for model improvement.

Revenue scales efficiently as customers expand call volumes, with larger healthcare organizations and RCM outsourcers representing the highest-value segments. The usage-based model creates natural expansion opportunities as customers automate additional call types and increase monthly volumes.

Competition

Vertically integrated RCM suites

FinThrive has introduced autonomous agents for eligibility verification and prior authorization as part of its revenue cycle management platform. The company uses its existing data infrastructure and payer relationships to offer automation across its 3,000-plus facility customer base.

Notable Health has expanded beyond patient-facing automation to include payer communication workflows, and now markets digital assistants that handle manual prior authorization calls. With approximately 150 health system customers, Notable cross-sells contact center automation alongside its core workflow products.

Pure-play payer calling startups

HealOS combines voice automation with portal scraping and robotic process automation for end-to-end eligibility and claims processing. The company's multi-channel approach addresses scenarios where phone calls alone cannot complete required tasks.

Thoughtful AI focuses specifically on healthcare back-office automation, including insurance verification and claims follow-up through AI agents. The platform integrates with existing healthcare software systems and targets workflow optimization.

Horizontal voice AI platforms

Synthflow, Retell, and similar platforms offer configurable voice automation that can be adapted for healthcare use cases. These companies compete primarily on price and technical flexibility, often undercutting specialized healthcare solutions.

The horizontal players lack healthcare-specific compliance features and workflow integrations, and their lower pricing pressures the market toward sub-$0.10 per completed minute rates.

TAM Expansion

New products

SuperDial can extend its voice AI capabilities to inbound patient communications, including appointment scheduling, prescription refills, and payment plan enrollment. The same underlying technology that handles complex payer conversations can automate high-volume patient service calls that providers currently route through live agents.

The January 2024 CMS Interoperability rule requires most US payers to expose FHIR-based prior authorization APIs by January 2027. SuperDial can evolve into an orchestration platform that intelligently routes requests between API calls and phone conversations based on payer capabilities and request complexity.

Security and compliance add-ons represent another expansion opportunity as synthetic voice fraud against insurers increased 475% in 2024. SuperDial's call recording, transcript generation, and audit trail capabilities could become standalone compliance products for payers and clearinghouses.

Customer base expansion

Large integrated delivery networks represent significant expansion opportunities, as organizations like Humana field approximately 80 million member calls annually. Many health systems lack resources to build internal AI calling capabilities and would benefit from SuperDial's proven HIPAA-compliant infrastructure.

Mid-market RCM outsourcers offer substantial growth potential, with one leading firm using SuperDial to cut manual calls by 70% and clear a 120,000-claim backlog in three weeks. Hundreds of similar billing companies face labor shortages and rising denial volumes that SuperDial's automation directly addresses.

Vertical expansion

Specialty healthcare segments like pharmacy benefit verification, durable medical equipment order follow-up, and dental plan eligibility checking face identical phone-based bottlenecks. SuperDial's existing dental service organization customers demonstrate the platform's adaptability across healthcare verticals.

Government and payer business process outsourcers need scalable solutions as they implement the 2027 API compliance requirements while maintaining phone-based backup systems. These organizations represent large-volume opportunities for SuperDial's automation platform.

Risks

payer API adoption: The 2027 CMS mandate requiring payers to expose prior authorization APIs could significantly reduce phone-based transaction volumes, undermining SuperDial's core value proposition. If payers successfully digitize most routine inquiries, the addressable market for voice automation shrinks substantially.

regulatory backlash: A $3.5M UnitedHealthcare TCPA settlement in February 2026 over AI robocalls surfaced regulatory risks around automated healthcare communications. Stricter consent requirements or call volume restrictions could limit SuperDial's operational flexibility and increase compliance costs.

competitive commoditization: Horizontal voice AI platforms are driving per-minute pricing below $0.10, while vertically integrated RCM suites bundle calling automation with existing services. SuperDial faces pressure from both low-cost generalists and comprehensive incumbents that can cross-sell voice capabilities to established customer bases.

DISCLAIMERS

This report is for information purposes only and is not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise constitutes a personal trade recommendation to you.

This research report has been prepared solely by Sacra and should not be considered a product of any person or entity that makes such report available, if any.

Information and opinions presented in the sections of the report were obtained or derived from sources Sacra believes are reliable, but Sacra makes no representation as to their accuracy or completeness. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and estimates contained in this report reflect a determination at its original date of publication by Sacra and are subject to change without notice.

Sacra accepts no liability for loss arising from the use of the material presented in this report, except that this exclusion of liability does not apply to the extent that liability arises under specific statutes or regulations applicable to Sacra. Sacra may have issued, and may in the future issue, other reports that are inconsistent with, and reach different conclusions from, the information presented in this report. Those reports reflect different assumptions, views and analytical methods of the analysts who prepared them and Sacra is under no obligation to ensure that such other reports are brought to the attention of any recipient of this report.

All rights reserved. All material presented in this report, unless specifically indicated otherwise is under copyright to Sacra. Sacra reserves any and all intellectual property rights in the report. All trademarks, service marks and logos used in this report are trademarks or service marks or registered trademarks or service marks of Sacra. Any modification, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, or selling any report is strictly prohibited. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Sacra. Any unauthorized duplication, redistribution or disclosure of this report will result in prosecution.